12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Namenda: Postmarketing study data

Researchers at the University of Southern California Keck School of Medicine and colleagues reported data from a meta-analysis of 431 patients with mild AD and 697 patients with moderate AD from 3 clinical trials of Namenda showing that there were no significant differences between Namenda and placebo on any outcome...

Read the full 238 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >